Termination of pregnancy: the AU general practice approach

Termination of pregnancy in Australia

Termination of pregnancy (TOP) is one of the most common reproductive health procedures in Australia, with approximately 80,000 occurring nationally each year. About one in four Australian women will have a TOP in her lifetime. General practitioners are central to this care — whether initiating medical TOP, providing non-directive options counselling, issuing referrals, or managing follow-up. Since Western Australia’s 2023 abortion law reform, TOP is now decriminalised across all eight Australian states and territories. The clinical and legal framework, however, varies significantly by jurisdiction, and confirming the relevant state law is part of the standard of care.

The two main methods are medical TOP (mifepristone + misoprostol, the MS 2 Step) for pregnancies up to 63 days gestation, and surgical TOP (suction aspiration or dilatation and evacuation) for a broader gestational range. Access barriers persist — only approximately 3–4% of Australian GPs hold MS 2 Step prescriber certification, and community pharmacy dispensing is concentrated in metropolitan areas. Telehealth pathways through MSI Choices Australia and Marie Stopes Australia have substantially addressed the rural and remote access gap.

A. Core clinical — the AU general-practice framework

Options counselling — non-directive first

Before initiating any clinical pathway, every patient presenting about an unintended pregnancy is entitled to non-directive, person-centred options counselling. RANZCOG’s Termination of Pregnancy guideline 2024 requires that four options are presented without steering: continuing the pregnancy and parenting; continuing the pregnancy and pursuing adoption or permanent care; medical TOP; and surgical TOP. The purpose is to support an informed, autonomous decision, not to direct the patient toward any particular choice.

Screen sensitively for reproductive coercion — where a partner, family member, or other person is influencing or controlling the patient’s reproductive decision. A covert telehealth and pharmacy dispensing pathway can be the safest option for patients in coercive or dangerous relationships. 1800RESPECT provides 24-hour crisis counselling and safety planning.

Workup before TOP

Confirm pregnancy, gestational age, and location before initiating any TOP regimen. The critical safety step is confirming an intrauterine pregnancy:

• Urine βhCG — confirms pregnancy
• Transvaginal ultrasound — recommended when gestational dates are uncertain, or when there is pain or bleeding; mandatory before medical TOP if there is any clinical uncertainty about intrauterine location. Administering mifepristone to an undiagnosed ectopic pregnancy is a serious patient safety event
• Haemoglobin / FBC — identify anaemia before significant bleeding is anticipated
• Blood group and antibody screen — Rh status determines anti-D requirement
• STI screen — chlamydia and gonorrhoea NAAT, syphilis serology, HIV, hepatitis B and C — to reduce post-procedural pelvic inflammatory disease risk and treat pre-procedure if positive
• Mental health enquiry — pre-existing mental health conditions are the dominant predictor of post-TOP wellbeing, not the TOP itself
• Cervical screening — complete opportunistically if due

Medical TOP — MS 2 Step (up to 9 weeks / 63 days)

The PBS-listed MS 2 Step combination is the standard first-line medical regimen for early TOP in Australian general practice:

Day 1: mifepristone 200 mg orally — blocks the progesterone receptor and sensitises the uterus to prostaglandins.

36–48 hours later: misoprostol 800 mcg buccal (most commonly prescribed in Australian ambulatory care), sublingual, or vaginal — induces uterine contractions and cervical softening.

Success rate is 95–98% up to 63 days gestation. Efficacy declines beyond this threshold — approximately 85% at 9–10 weeks. A hospital-based pathway, or direct referral to a specialist service, is preferred for pregnancies beyond 9 weeks.

Counsel patients to expect significant cramping and heavy bleeding within 1–4 hours of the misoprostol dose, tapering over 1–2 weeks. Clots up to the size of a 50-cent coin are expected. Nausea, vomiting, diarrhoea, chills, and transient fever in the 24 hours after misoprostol are prostaglandin-mediated effects, not signs of infection.

Analgesia plan (WHO Abortion Care Guideline 2022): ibuprofen 400–600 mg every 4–6 hours plus paracetamol 1 g every 4–6 hours, with codeine 30 mg or oxycodone 5 mg as breakthrough. A heating pad is a low-cost adjunct.

Anti-emetic: offer ondansetron 4–8 mg or metoclopramide 10 mg orally with the misoprostol prescription to reduce vomiting and improve completion.

Confirm completion at 2–3 weeks using a low-sensitivity urine βhCG (cutoff 1000 mIU/mL) or serial quantitative serum βhCG (≥80% decline from pre-procedure at 7 days). Routine pelvic ultrasound at this point is not required unless the patient is symptomatic or βhCG is persistently elevated.

Surgical TOP

Surgical TOP achieves approximately 99% success and is the preferred method when gestational age exceeds 9 weeks, medical contraindications to mifepristone exist (chronic adrenal insufficiency, porphyria, long-term corticosteroid use, significant coagulopathy, IUD in situ), or when the patient prefers an in-clinic procedure:

• Suction aspiration (vacuum aspiration): up to 14 weeks gestation; day procedure under local anaesthetic with paracervical block ± procedural sedation, or general anaesthesia; takes 5–10 minutes; outpatient / day surgery
• Dilatation and evacuation (D&E): 14–22 weeks; specialist service; cervical preparation with mifepristone 200 mg 24–48 hours prior, osmotic dilators, and misoprostol
• Late TOP (beyond 22–24 weeks): usually for serious fetal anomaly indication; multidisciplinary committee process; feticide precedes evacuation in most jurisdictions

Antibiotic prophylaxis is recommended for all surgical TOP: doxycycline 200 mg orally as a single pre-procedure dose reduces post-procedural infection by approximately 40%, per the Achilles BJOG 2012 meta-analysis and WHO 2022.

Anti-D prophylaxis

Anti-D administration follows RANZCOG Anti-D 2024 and Australian Red Cross Lifeblood guidance:

• Any surgical TOP at any gestation, or medical TOP at or beyond 10 weeks: anti-D 250 IU intramuscularly within 72 hours; 625 IU for gestations at or beyond 20 weeks
• Medical TOP under 10 weeks (less than 70 days): anti-D is not routinely required per current RANZCOG 2024 and WHO 2022 guidance, which found no measurable fetomaternal haemorrhage at this gestation. This represents a change from older universal practice. Document the discussion and the patient’s informed choice. Anti-D can be offered at patient request.

Post-procedure contraception — same day

Effective ovulation can resume within 8–10 days of completing a TOP. Post-procedure contraception should be offered and started at the time of TOP, with long-acting reversible contraception (LARC) strongly encouraged (RANZCOG LARC Position Statement 2024):

• Implanon NXT (etonogestrel implant): inserted on the same day as mifepristone, or immediately post-surgical TOP
• Hormonal IUD (Mirena, Kyleena): inserted on the day of surgical TOP, or within one week of confirmed completed medical TOP
• Depot medroxyprogesterone acetate (DMPA): same-day administration acceptable
• Combined oral contraceptive pill or progestogen-only pill: start day of mifepristone or surgical procedure

B. Evidence appraisal

Medical versus surgical first-line at ≤9 weeks

The Cochrane systematic review by Kulier et al. (2011) — the primary evidence base — found equivalent efficacy and safety for medical and surgical TOP at ≤9 weeks. Medical TOP is preferred for its home-based nature and patient autonomy; surgical is preferred when contraindications to mifepristone exist, or when the patient prefers a definitive in-clinic outcome. Patient preference should guide the choice where both options are available.

Telehealth medical TOP — equivalent to in-person

Aiken et al. (BMJ 2021) — a cohort study of over 29,000 patients receiving telehealth medication abortion in the UK — demonstrated equivalent safety and efficacy compared to in-person care, with fewer service barriers and lower cost. Australian MSI Choices and Marie Stopes service data are consistent with this finding. Telehealth is appropriate when intrauterine location is confirmed and ectopic risk factors are absent. A 2023 Department of Health and Aged Care telehealth exemption means the usual 12-month prior face-to-face relationship requirement does not apply to TOP and contraception consultations, enabling new patients to access telehealth TOP directly.

Post-TOP psychological outcomes

Multiple systematic reviews — including the APA Task Force Report (2008), the Charles et al. BMJ systematic review (2008), and the US Turnaway Study (Foster 2020) — consistently find no excess long-term mental health harm attributable to TOP compared to continuing an unwanted pregnancy. Pre-existing mental health conditions are the strongest predictor of post-TOP wellbeing. “Post-abortion syndrome” is not a recognised diagnostic entity and has been rejected by RANZCOG, RCOG, and the APA. Mental Health Care Plans (MBS items 2715/2717) are appropriate when the patient requests psychological support — not routinely.

Abortion pill reversal — no evidence, active harm

Creinin et al. (Obstet Gynecol 2020) conducted a randomised controlled trial of progesterone after mifepristone for “reversal”; the trial was halted early because of haemorrhage in the placebo arm. RANZCOG 2024 and ACOG do not endorse this practice. If a patient is ambivalent after taking mifepristone, counsel them toward completing the regimen or arranging surgical TOP — not progesterone-based reversal attempts.

C. Conscientious objection and the Australian legal framework

Every Australian jurisdiction requires GPs who decline to provide TOP to:

1. Inform the patient clearly that they are declining
2. Provide referral information to a non-objecting provider without delay

There is no jurisdiction in which a GP can refuse and send the patient away without referral. In an emergency where TOP is required to preserve the patient’s life, the conscience clause does not apply.

Children by Choice maintains a current summary of Australian abortion law by state and territory, including gestational thresholds, committee requirements, and 2023 reform summaries. Verify the law applicable in your state — the landscape has changed significantly since 2017.

GP — how to become an MS 2 Step prescriber

Any GP can prescribe MS 2 Step after completing the free 2–3 hour online certification at MS Health. No exam; RACGP CPD-accredited. The 2023 reforms removed the prior 5-script cap, special prescribing authority, and prescriber registration requirement. Community pharmacists can now also complete a parallel certification and dispense independently, broadening rural dispensing capacity.

D. Australian operations

Referral pathways when you are not a prescriber

When a patient needs TOP and you are not an MS 2 Step prescriber, or you conscientiously object and have referred:

• Telehealth medical TOP (≤9 weeks): MSI Choices Australia, Marie Stopes Australia
• Surgical TOP day clinics: Marie Stopes, MSI Choices, Family Planning Australia state branches, public hospital women’s health units
• Mid-trimester and late TOP: public tertiary obstetric services — Royal Women’s Hospital (Melbourne), Royal Hospital for Women (Sydney), King Edward Memorial Hospital (Perth), Royal Brisbane and Women’s Hospital, Flinders Medical Centre (Adelaide), Royal Hobart Hospital, Royal Darwin Hospital, Canberra Hospital
• Counselling and decision support: Children by Choice 1800 177 725, 1800 My Options (Victoria) 1800 696 784

MBS and PBS

Standard GP consultations (MBS items 23 / 36 / 44) apply for assessment and counselling. The 2023 DoHA exemption allows telehealth billing for TOP and contraception without the 12-month prior face-to-face requirement. Obstetric ultrasound (items 55070 / 55700 TV ultrasound), pathology (FBC 65070; blood group and Rh 65096; quantitative βhCG 66695; STI screens 73529, 69384), and surgical TOP (35643 suction aspiration; 35633 D&E) are MBS-rebatable. The MS 2 Step combination pack is PBS-listed, Authority Required (Streamlined), at concession cost ($7.30) and general patient cost (~$31.60).

Documentation minimum

Confirm: intrauterine pregnancy location and gestational age confirmed; non-directive counselling provided with all four options explored; informed consent documented (success rate, failure rates, bleeding, infection, future fertility, psychological considerations); Rh status and anti-D decision; STI screen results and treatment if positive; contraception plan and start date; conscientious objection and referral if applicable; follow-up plan for completion confirmation at 2–3 weeks.

E. Special populations

Aboriginal and Torres Strait Islander patients. Provide culturally safe, non-judgmental care. Engage Aboriginal Health Workers or Liaison Officers where available. Address social determinants including domestic and family violence. Telehealth pathways reduce geographic barriers substantially.

Adolescents. In all Australian jurisdictions, adolescents with capacity to understand the procedure can consent to TOP independently — Gillick and Fraser competence applies. Some jurisdictions have specific adolescent provisions; verify local law. Ensure access to counselling and support services.

Patients experiencing reproductive coercion. A covert telehealth pathway — where medications are dispensed by pharmacy without requiring a clinic visit — can be the safest route when there is concern about a controlling partner monitoring in-person attendance. 1800RESPECT 1800 737 732 provides 24-hour support.

Patients with anaemia or coagulopathy. Surgical TOP may be preferred; specialist consultation advised before initiating medical TOP. Correct anaemia where possible before a procedure.

Late TOP for fetal anomaly. This is a specialist pathway involving maternal-fetal medicine, genetics counselling, multidisciplinary team review, and jurisdiction-specific committee or two-doctor approval processes. Initiate tertiary referral promptly and without delay when fetal anomaly is confirmed.

When to escalate

Involve specialist or emergency services when:

• Gestational age exceeds 9 weeks and no in-house surgical capability — refer to surgical service promptly
• Clinical uncertainty about intrauterine location — urgent specialist review before any TOP regimen is started
• Heavy post-procedure haemorrhage — more than 2 pads per hour for 2 consecutive hours, syncope, or haemodynamic compromise — transfer to emergency department
• Fever beyond 24 hours after misoprostol, peritonism, foul vaginal discharge, or shock without fever — sepsis workup and hospital admission; consider Clostridium sordellii
• Ongoing viable pregnancy confirmed at 2–3 week follow-up — surgical TOP required; teratogenic exposure makes continuation inadvisable
• Mid-trimester or late TOP indication — tertiary obstetric service
• Domestic violence or reproductive coercion — 1800RESPECT and social work involvement

What this article is and is not

This is general health information drawn from current Australian clinical guidelines — RANZCOG 2024, WHO Abortion Care Guideline 2022, and major evidence reviews. It is not personal medical advice and does not substitute for a consultation with a qualified practitioner who knows your individual circumstances and your state’s current legislation. Gestational thresholds and procedural requirements change as legislation evolves — always verify current state law via your state health department or Children by Choice.

For counselling and access: Children by Choice 1800 177 725, 1800 My Options (Victoria) 1800 696 784, MSI Choices, Marie Stopes Australia, HealthDirect.

For safety concerns: 1800RESPECT 1800 737 732.

---

Sources cited

1. RANZCOG — Termination of Pregnancy 2024
2. RANZCOG — Anti-D Prophylaxis 2024
3. RANZCOG — Long-Acting Reversible Contraception 2024
4. RANZCOG — Conscientious Objection 2022
5. WHO Abortion Care Guideline 2022
6. Cochrane — Medical methods for first trimester abortion (Kulier 2011)
7. Aiken AMM et al. — Telemedicine medication abortion (BMJ 2021)
8. Creinin MD et al. — Mifepristone antagonization with progesterone RCT (Obstet Gynecol 2020)
9. Achilles SL et al. — Antibiotic prophylaxis for TOP (BJOG 2012)
10. APA Task Force — Mental health and abortion 2008
11. Charles VE et al. — Abortion and long-term mental health (BMJ 2008)
12. MS Health — Prescriber information and certification
13. Family Planning Alliance Australia
14. Children by Choice — Australian abortion laws
15. MSI Choices Australia
16. Marie Stopes Australia
17. 1800 My Options Victoria
18. Australian Red Cross Lifeblood — Anti-D guidance
19. TGA
20. PBS Schedule
21. HealthDirect — Termination of pregnancy
22. 1800RESPECT